Anhui Anke BioTech Group (300009) — Cash Flow Reinvestment Rate
Anhui Anke BioTech Group (300009) has a Cash Flow Reinvestment Rate of 0.09x as of September 2025, reinvesting CN¥21.63 Million (capex CN¥21.63 Million ) from operating cash flow of CN¥240.51 Million. See how much free cash does Anhui Anke BioTech Group generate to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Anhui Anke BioTech Group Cash Flow Reinvestment Rate (2006–2025)
Historical reinvestment intensity for Anhui Anke BioTech Group across 20 annual periods. For the full cash flow conversion analysis, see 300009 cash flow conversion.
Annual Cash Flow Reinvestment Rate for Anhui Anke BioTech Group (2006–2025)
Year-by-year capital reinvestment analysis for Anhui Anke BioTech Group. See 300009 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.55x | CN¥473.05 Million | CN¥863.22 Million | CN¥126.89 Million | ▲ +114.7% |
| 2024 | 0.26x | CN¥174.93 Million | CN¥685.37 Million | CN¥117.22 Million | ▼ -60.6% |
| 2023 | 0.65x | CN¥617.17 Million | CN¥952.97 Million | CN¥195.34 Million | ▼ -21.3% |
| 2022 | 0.82x | CN¥575.41 Million | CN¥698.98 Million | CN¥474.34 Million | ▲ +108.1% |
| 2021 | 0.40x | CN¥234.30 Million | CN¥592.17 Million | CN¥131.23 Million | ▼ -52.8% |
| 2020 | 0.84x | CN¥389.76 Million | CN¥464.80 Million | CN¥138.52 Million | ▼ -63.8% |
| 2019 | 2.32x | CN¥684.87 Million | CN¥295.63 Million | CN¥186.48 Million | ▲ +190.7% |
| 2018 | 0.80x | CN¥229.13 Million | CN¥287.49 Million | CN¥213.72 Million | ▼ -4.5% |
| 2017 | 0.83x | CN¥234.17 Million | CN¥280.63 Million | CN¥131.78 Million | ▲ +207.4% |
| 2016 | 0.27x | CN¥70.04 Million | CN¥258.01 Million | CN¥69.18 Million | ▼ -75.4% |
| 2015 | 1.10x | CN¥131.05 Million | CN¥118.73 Million | CN¥36.95 Million | ▲ +36.3% |
| 2014 | 0.81x | CN¥88.04 Million | CN¥108.68 Million | CN¥88.04 Million | ▲ +36.3% |
| 2013 | 0.59x | CN¥31.64 Million | CN¥53.21 Million | CN¥31.64 Million | ▼ -46.2% |
| 2012 | 1.10x | CN¥59.42 Million | CN¥53.80 Million | CN¥59.42 Million | ▼ -90.4% |
| 2011 | 11.49x | CN¥82.54 Million | CN¥7.18 Million | CN¥82.54 Million | ▲ +4776.0% |
| 2010 | 0.24x | CN¥11.18 Million | CN¥47.43 Million | CN¥11.18 Million | ▼ -27.3% |
| 2009 | 0.32x | CN¥12.54 Million | CN¥38.67 Million | CN¥12.54 Million | ▲ +29.4% |
| 2008 | 0.25x | CN¥6.52 Million | CN¥26.04 Million | CN¥6.52 Million | ▼ -5.7% |
| 2007 | 0.27x | CN¥9.32 Million | CN¥35.10 Million | CN¥9.32 Million | ▲ +206.2% |
| 2006 | 0.09x | CN¥2.57 Million | CN¥29.66 Million | CN¥2.57 Million | — |